Neonatal wearable device for colorimetry-based real-time detection of jaundice with simultaneous sensing of vitals

66Citations
Citations of this article
116Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Neonatal jaundice occurs in >80% of newborns in the first week of life owing to physiological hyperbilirubinemia. Severe hyperbilirubinemia could cause brain damage owing to its neurotoxicity, a state commonly known as kernicterus. Therefore, periodic bilirubin monitoring is essential to identify infants at-risk and to initiate treatment including phototherapy. However, devices for continuous measurements of bilirubin have not been developed yet. Here, we established a wearable transcutaneous bilirubinometer that also has oxygen saturation (SpO2) and heart rate (HR) sensing functionalities. Clinical experiments with neonates demonstrated the possibility of simultaneous detection of bilirubin, SpO2, and HR. Moreover, our device could consistently measure bilirubin during phototherapy. These results demonstrate the potential for development of a combined treatment approach with an automatic link via the wearable bilirubinometer and phototherapy device for optimization of the treatment of neonatal jaundice.

Cite

CITATION STYLE

APA

Inamori, G., Kamoto, U., Nakamura, F., Isoda, Y., Uozumi, A., Matsuda, R., … Ota, H. (2021). Neonatal wearable device for colorimetry-based real-time detection of jaundice with simultaneous sensing of vitals. Science Advances, 7(10). https://doi.org/10.1126/sciadv.abe3793

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free